TECH — Bio-Techne
Data coverage, completeness and provenance for Bio-Techne in the Stock Market API — Health Care · Biotechnology.
Stored price coverage
Source date: 2026-11-19T21:00:00. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-11-19 | 72.7000 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-18 | 72.7500 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-17 | 72.6300 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-16 | 72.7900 | USD | yfinance | Split- and dividend-adjusted close |
| 2026-11-13 | 72.8000 | USD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/TECH/prices · Price parameters and adjustment semantics
No archived filings are currently stored for this listing.
Profile
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
Employees: 3,000 · Website: https://www.bio-techne.com · Profile fields populated: 75%
Data completeness by statement
Share of stored fields populated in the anchor reporting period (FY2026), primary source sec_edgar. Full per-field breakdown: GET /api/v1/companies/TECH/financials.
Financial statement coverage (USD)
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (USD) | 2026-06-30 | 31 | sec_edgar | ||||
| FY2025 (USD) | 2025-06-30 | 31 | sec_edgar | ||||
| FY2024 (USD) | 2024-06-30 | 31 | sec_edgar | ||||
| FY2023 (USD) | 2023-06-30 | 31 | sec_edgar | ||||
| FY2022 (USD) | 2022-06-30 | 31 | sec_edgar |
Get TECH data via the API
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Company profile
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/TECH
Financial statements
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/TECH/financials
Computed ratios
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/TECH/metrics/summary
News & announcements
Dated press releases and announcements with source links.
GET /api/v1/companies/TECH/news
Quick start
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/TECH
Query TECH programmatically
Free tier — instant API key. Built for AI agents.
Other NASDAQ · Health Care companies covered
Frequently Asked Questions
- What data does the API provide for TECH?
- Stored coverage for TECH: price data available, financial statements available, 0 archived filings. REST endpoints are under /api/v1/companies/TECH; inspect available source metadata for provenance.
- How complete is TECH's financial data?
- The anchor reporting period (FY2026) has 100.0% of the 17 core statement fields populated. Primary source: sec_edgar.
- What reporting periods are covered for TECH?
- 5 fiscal-year periods are stored (FY2022–FY2026), with per-period field counts and source tags available via /api/v1/companies/TECH/financials.
- Where does TECH's data come from?
- Stored price source: yfinance. Primary source for the statement snapshot: sec_edgar. Inspect available period and field source tags at /api/v1/companies/TECH/financials; missing tags do not establish provenance.